Placebo to MK-7684A - normal saline clinical trials

A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-small Cell Lung Cancer With Progressive Disease After Treatment With a Platinum Doublet Chemotherapy and Immunotherapy

This study is testing a new medicine (MK-7684A) alone or with a standard cancer drug (docetaxel) for advanced non-small cell lung cancer that has continued to grow after previous treatments. Researchers want to see if these new treatments can stop the cancer from growing for longer than docetaxel alone.